1He D,Wang M,Chen X,et al, Ethnic differences in distribution of serum prostate -specific antigen:a study in a healthy Chinese male population [ J ]. Urology ,2004,63 (4) :722-726.
2Chinegwundoh F,Enver M,Lee A,et al. Risk and presenting features of prostate cancer amongst African -Caribbean, South Asian and European men in North- east London [ J]. BJU Int,2006,98 (6) :1216-1220.
3McFall SL. Use and awareness of prostate specific antigen tests and race/ethnicity [ J ]. J Urol,2007,177 (4) : 1475 -1480.
4Presti JC. Prostate biopsy:current status and limitations [J]. Rev Urol, 2007,9(3) :93-98.
5Singh H, Canto El, Shariat SF, et al. Improved detection of clinically sig nificant,curable prostate cancer with systematic 12 - core biopsy [ J ]. J Uro1,2004,171 (3) : 1089-1092.
6Applewhite JC, Matlaga BR, McCullough DL. Results of the 5 region prostate biopsy method:the repeat biopsy population [ J ]. J Uro1,2002, 168(2) :500-503.
7Herrala AM,Porvari KS,Kyllonen AP,et al. Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene ex pression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue [ J ]. Cancer,2001,92 (12) :2975-2984.
9Raaijmakers R, de Vries SH, Blijenberg BG, et al. hK2 and free PSA, a prognostic combination in predicting minimal prostate cancer in screen - detected men within the PSA range 4 - 10 ng/ml [ J ]. Eur Urol, 2007,52(5) : 1358-1364.
10O Keefe DS, Bacich D J, Heston WD. Comparative analysis of prostate - specific membrane antigen (PSMA) versus a prostate - specific mem- brane antigen - like gene [ J ]. Prostate, 2004,58 ( 2 ) :200-210.
